SCHEMBL2869134

SCHEMBL2869134

O=C(Nc1ccccc1)c1snnc1C1CC1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.61
ABCC8 Q09428 1/20 0.58
KCNJ11 Q14654 1/20 0.58
GAA P10253 3/20 0.48
MAPT P10636 5/20 0.46
KDM4E B2RXH2 2/20 0.46
CRACR2A Q9BSW2 3/20 0.45
RAB9A P51151 6/20 0.43
RECQL P46063 1/20 0.43
NPC1 O15118 5/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 4/20 0.41
TP53 P04637 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2859024 0.83 ABCC8 (0.53) LMNAABCC8KCNJ11MAPTRAB9A
SCHEMBL2863835 0.81 CBLB (0.48) LMNAABCC8KCNJ11
SCHEMBL2864396 0.81 USP36 (0.52) LMNAABCC8KCNJ11MAPTCRACR2A
SCHEMBL12852342 0.80 ABCC8 (0.50) LMNAABCC8KCNJ11MAPTKDM4E
SCHEMBL2872524 0.80 ABCC8 (0.58) ABCC8KCNJ11NPC1MEN1KMT2A
SCHEMBL2859438 0.79 ABCC8 (0.49) LMNAABCC8KCNJ11GAAKDM4E
SCHEMBL2862957 0.78 ABCC8 (0.49) ABCC8KCNJ11GAAKDM4ERAB9A
SCHEMBL2868108 0.77 KDM4E (0.55) LMNAABCC8KCNJ11MAPTKDM4E
SCHEMBL2866592 0.77 MEN1 (0.66) LMNAABCC8KCNJ11MAPTKDM4E
SCHEMBL2868672 0.77 MEN1 (0.66) LMNAABCC8KCNJ11MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200457-A1 4-Cyclopropyl-1,2,3,-Thiadiazole Compound, Agrohorticultural Plant Disease Controlling Agent And Method Of Using The Same NIHON NOHYAKU CO., LTD. (JP) 2008-08-21 US claimed
CN-101128445-A 4-cyclopropyl-1,2,3-thiadiazole derivative, agrohorticultural plant disease controlling agent, and method for using the same NIHON NOHYAKU CO LTD (JP) 2008-02-20 CN claimed
EP-1852428-A1 4-CYCLOPROPYL-1,2,3-THIADIAZOLE COMPOUND, AGROHORTICULTURAL PLANT DISEASE CONTROLLING AGENT AND METHOD OF USING THE SAME Nihon Nohyaku Co., Ltd. (JP) 2007-11-07 EP claimed
CN-101128445-B 4-cyclopropyl-1,2,3-thiadiazole derivative, agrohorticultural plant disease controlling agent, and method for using the same NIHON NOHYAKU CO LTD 2012-01-18 CN disclosed
US-7786040-B2 4-cyclopropyl-1,2,3,-thiadiazole compound, agrohorticultural plant disease controlling agent and method of using the same NIHON NOHYAKU CO., LTD. (JP) 2010-08-31 US disclosed
US-20080200457-A1 4-Cyclopropyl-1,2,3,-Thiadiazole Compound, Agrohorticultural Plant Disease Controlling Agent And Method Of Using The Same NIHON NOHYAKU CO., LTD. (JP) 2008-08-21 US disclosed
CN-101128445-A 4-cyclopropyl-1,2,3-thiadiazole derivative, agrohorticultural plant disease controlling agent, and method for using the same NIHON NOHYAKU CO LTD (JP) 2008-02-20 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200457-A1 4-Cyclopropyl-1,2,3,-Thiadiazole Compound, Agrohorticultural Plant Disease Controlling Agent And Method Of Using The Same CBR3, CBR1, OSR1 LMNA 4471/4885ABCC8 1005/4885KCNJ11 1207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.